This report from Public Health England provides an update on the recent epidemiology of hepatitis C in London. Among the report's statistics are an estimate that 63% of people who inject drugs (PWID) in London had ever been infected with hepatitis C in 2018, with 41% of those ever infected having a current hepatitis C infection. It is estimated that 18% of PWID were unaware of their infection (lower than the 35% unaware in England as a whole). In 2017/18, 87% of eligible clients of drug treatment services received a hepatitis C test, a small increase from 86% in 2016/2017.
Resources
Commissioner
NHS England, CCGs and local authorities are all responsible for commissioning different parts of hepatitis C testing, treatment and care. Find here tools, templates and other relevant documents to assist commissioners with their responsibilities to ensure hepatitis C patients are diagnosed and receive high quality care.
Showing 1 to 10 of 303 resources
-
Hepatitis C in London: 2019 report
England, Greater London 17 Feb 2020 Reports & Research PDF -
Infected Blood Inquiry expert report on psychosocial issues
In February 2020, the Infected Blood Inquiry published this expert report on psychosocial issues resulting from being infected by hepatitis C, HIV and hepatitis B through contaminated blood on the NHS in the 1980s and 90s.UK Reports & Research PDF -
Good practice case study: Intensive testing at HMP Low Newton
This good practice case study explores how HMP Low Newton micro-eliminated hepatitis C by running an intensive testing weekend in January 2020 which had a phenomenal 99.3% uptake rate.UK Case study PDF -
The Hepatitis C Trust: Peer-to-peer programme
This video provides an overview of The Hepatitis C Trust's peer-to-peer support work, which involves staff and volunteer peers with lived experience of hepatitis C providing support to those at risk of and living with hepatitis C, raising awareness and supporting access to testing and treatment.UK 30 Jan 2020 Training, Tools & Templates, Strategy & Planning Video -
Leave No One Behind: Engaging and empowering people in hepatitis C care and treatment through peer support
This report provides an overview of The Hepatitis C Trust's peer-to-peer support work, outlining the various ways the charity's peers supports people at risk of or living with hepatitis C, detailing the results the peer project has achieved and explaining challenges that have been overcome in delivering the programme.UK 30 Jan 2020 Reports & Research, Strategy & Planning PDF -
One Recovery Bucks BBV Pathway
This best practice resource details the One Recovery Bucks blood borne virus pathway implemented in 2016. The pathway, involving partnership working with the local NHS Trust is much simpler than the previous pathway and is all completed ‘in-house’ at the One Recovery Bucks community drug and alcohol service. The new pathway has resulted in an increase in those who test positive advancing to access treatment from 18% to over 90%.UK 10 Jan 2020 Tools & Templates PDF -
Good practice case study: One Recovery Bucks BBV Pathway
This good practice case study focuses on the One Recovery Bucks drugs service BBV pathway. Implementation of the pathway has seen the proportion of patients who test positive for hepatitis C going on to access treatment increase from 18% to over 90%.UK 10 Jan 2020 Case study PDF -
Staying Alive in Scotland: Strategies to Prevent Drug Deaths
This updated toolkit, a partnership between the Scottish Government and Scottish Drugs Forum, updates the original report produced three years ago. The resource notes that DAA treatments for hepatitis C provide an opportunity to prevent drug-related deaths, but that opportunities to test for hepatitis C are being missed.Scotland 20 Dec 2019 Reports & Research PDF -
Shooting Up: Infections among people who inject drugs in the UK, 2018
This December 2019 update to the Shooting Up: Infections among people who inject drugs in the UK, produced by Public Health England, provides updated data to the end of 2018. The report says that there is early evidence for a reduction in chronic hepatitis C prevalence among injecting drug users, but that rates of new infection are unchanged, including amongst individuals who have recently started injecting.UK 20 Dec 2019 Reports & Research PDF -
World Hepatitis Day 2019: Global Summary Report
The World Hepatitis Alliance has produced a report summarising activity for World Hepatitis Day 2019, including a global map of activity and regional reports.Rest of World 19 Dec 2019 Reports & Research PDF